Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Infection01:20

Infection

11.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

524
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
524
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

676
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
676
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Stages of Infection01:26

Stages of Infection

64.7K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
64.7K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Cannabinoid and adenosine A<sub>2A</sub> receptor crosstalk regulates postnatal and adult hippocampal neurogenesis.

British journal of pharmacology·2026
Same author

Aspects of the Postembryonic Development of the Mud Dragons <i>Campyloderes</i> cf. <i>vanhoeffeni</i> and <i>Ryuguderes casarrubiosi</i> (Kinorhyncha, Campyloderidae).

Zoological studies·2026
Same author

Author Correction: A µ-opioid receptor superagonist analgesic with minimal adverse effects.

Nature·2026
Same author

Dopaminergic hypersensitivity of the opioid-responsive striatal-entopeduncular pathway in a rodent model of restless legs syndrome.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

A µ-opioid receptor superagonist analgesic with minimal adverse effects.

Nature·2026
Same author

P2Y<sub>14</sub> receptor in the nervous system: Pharmacology, mechanisms, and therapeutic potential.

Pharmacology & therapeutics·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 7, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K

Ciencia básica y patogénesis

Paula Subirana1, Núria Sánchez1, Francisco Ciruela1

  • 1Universitat de Barcelona, Barcelona, Barcelona, Spain.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 27, 2025
PubMed
Resumen
Este resumen es generado por máquina.

Los cannabinoides naturales, tetrahidrocannabinol (THC) y cannabidiol (CBD), modulan la actividad cerebral en un modelo de ratón de la enfermedad de Alzheimer.

Palabras clave:
cannabinoidesenfermedad de AlzheimerneurotransmisoresTHCCBD

Más Videos Relacionados

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Videos de Experimentos Relacionados

Last Updated: Jan 7, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K
A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Área de la Ciencia:

  • Neurociencia; Farmacología; Investigación de la Enfermedad de Alzheimer

Sus antecedentes:

  • Estudios previos mostraron que dosis no psicotrópicas de THC y CBD reducen el deterioro cognitivo y los niveles de glutamato en el hipocampo en ratones APP/PS1.
  • La enfermedad de Alzheimer (EA) se asocia con deterioro cognitivo y síntomas no cognitivos, potencialmente relacionados con la desregulación de neurotransmisores.

Objetivo del estudio:

  • Investigar si los cannabinoides naturales (THC y CBD) modulan la actividad dopaminérgica en áreas límbicas relevantes para los síntomas no cognitivos de la EA.
  • Evaluar el efecto del tratamiento crónico con THC y CBD sobre la dinámica de neurotransmisores en un modelo animal de la enfermedad de Alzheimer.

Principales métodos:

  • Se utilizaron biosensores de glutamato y dopamina con fotometría de fibra para medir los niveles de neurotransmisores en el hipocampo y el núcleo accumbens (NAcc).
  • Los experimentos se realizaron en ratones APP/PS1 anestesiados y despiertos durante grabaciones electrofisiológicas y pruebas conductuales (reconocimiento de objetos novedosos, campo abierto, sociabilidad, prepulso inhibición).

Principales resultados:

  • El tratamiento crónico con THC y CBD normalizó los picos de glutamato en el hipocampo durante una tarea de memoria en ratones con EA en etapa temprana.
  • Los ratones con EA en etapa avanzada mostraron una dinámica alterada de dopamina en el NAcc, similar a rasgos similares a la psicosis, que mejoraron parcialmente con el tratamiento con THC y CBD.

Conclusiones:

  • La combinación de THC y CBD modula la actividad glutamatérgica del hipocampo y, posteriormente, reduce las alteraciones dopaminérgicas en las áreas límbicas en un modelo de ratón de EA.
  • Estos hallazgos sugieren que los cannabinoides naturales pueden ofrecer una estrategia terapéutica tanto para los síntomas cognitivos como para los no cognitivos de la enfermedad de Alzheimer.